Antimicrobial advantage: Augmenting pasteurized pooled donor human breast milk from human milk bank with human milk fortifier and probiotics against pathogens linked to necrotizing enterocolitis

Paper Details

Research Paper 10/02/2025
Views (1070)
current_issue_feature_image
publication_file

Antimicrobial advantage: Augmenting pasteurized pooled donor human breast milk from human milk bank with human milk fortifier and probiotics against pathogens linked to necrotizing enterocolitis

Vikraman Kalidoss, Gayathiri Govindaraju, S. S. Sudha, P. Sabarish, Suja Mariam
Int. J. Biosci. 26(2), 224-231, February 2025.
Copyright Statement: Copyright 2025; The Author(s).
License: CC BY-NC 4.0

Abstract

Breast Milk is essential for neonates, providing vital nutrients and immunological protection. When a mother’s Own Milk (MOM) is unavailable, Pasteurized pooled donor Human Breast Milk (PHBM) from Human Milk Bank (HMB) is a suitable alternative. This study investigates the antimicrobial properties of freshly Expressed Breast Milk (EBM), Unpasteurized Pooled Donor Breast Milk (UPHBM), and PHBM, including various fortifications with Human Milk Fortifiers (HMF) and probiotics Bifidobacterium breve-M16-V (B. breve) and Limosilactobacillus reuteri-DSM17938 (L. reuteri). Findings indicate that long storage and pasteurization significantly diminish the bactericidal activity of breast milk. However, fortifying PHBM with HMF and specific probiotics enhances its antimicrobial effects against bacteria associated with Necrotizing Enterocolitis (NEC). Despite these enhancements, Methicillin-Resistant Staphylococcus aureus (MRSA) remained unaffected, highlighting pathogen-specific variability. Overall, fortifying PHBM at HMB may help restore nutritional and protective qualities lost during pasteurization, offering improved antimicrobial protection for preterm infants at risk of NEC.

Baker S, Niranjan RS, Manju HK, Shayista H. 2023. Efficacy of breast milk components against microbial pathogens to combat drug-resistance. Microbe 100010, 1–8. https://doi.org/10.1016/j.microb.2023.100010.

Björkstén B, Burman LG, De Château P, Fredrikzon B, Gothefors L, Hernell O. 1980. Collecting and banking human milk: To heat or not to heat? British Medical Journal 281(6243), 765–769. https://doi.org/10.1136/bmj.281.6243.765.

Bozzi Cionci N, Baffoni L, Gaggìa F, Di Gioia D. 2018. Therapeutic microbiology: The role of Bifidobacterium breve as a food supplement for the prevention/treatment of pediatric diseases. Nutrients 10(11), 1723. https://doi.org/10.3390/nu10111723.

Chen HY, Allen JC. 2001. Human milk antibacterial factors: The effect of temperature on defense systems. Advances in Experimental Medicine and Biology 501, 341–348.

Kalidoss V, Govindaraju G, Sudha SS, Senthil Kumar P, Shanmuga Priya V. 2022. Human milk oligosaccharides an inevitable supplement for newborns. International Organisation of Scientific Research Journal of Biotechnology and Biochemistry 8(1), 23–27. https://doi.org/10.9790/264X-08012327.

Koenig A, de Albuquerque Diniz EM, Barbosa SF, Vaz FA. 2005. Immunologic factors in human milk: The effects of gestational age and pasteurization. Journal of Human Lactation 21(4), 439–443. https://doi.org/10.1177/0890334405280652.

Lubiech K, Twarużek M. 2020. Lactobacillus bacteria in breast milk. Nutrients 12(12), 3783. https://doi.org/10.3390/nu12123783.

Martínez-Costa C, Silvestre MD, López MC, Plaza A, Miranda M, Guijarro R. 2007. Effects of refrigeration on the bactericidal activity of human milk: A preliminary study. Journal of Pediatric Gastroenterology and Nutrition 45(2), 275–277. https://doi.org/10.1097/MPG.0b013e31805de507.

McPherson RJ, Wagner CL. 2001. The effect of pasteurization on transforming growth factor alpha and transforming growth factor beta 2 concentrations in human milk. Advances in Experimental Medicine and Biology 501, 559–566. https://doi.org/10.1007/978-1-4615-1371-1_70.

Mu Q, Tavella VJ, Luo XM. 2018. Role of Lactobacillus reuteri in human health and diseases. Frontiers in Microbiology 9(757), 1–17. https://doi.org/10.3389/fmicb.2018.00757.

Olivares M, Díaz-Ropero MP, Martín R, Rodríguez JM, Xaus J. 2006. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. Journal of Applied Microbiology 101(1), 72–79. https://doi.org/10.1111/j.1365-2672.2006.02981.x.

Patole S, Keil AD, Chang A, Nathan E, Doherty D, Simmer K, Esvaran M, Conway P. 2014. Effect of Bifidobacterium breve M-16V supplementation on fecal Bifidobacteria in preterm neonates- A randomised double-blind placebo-controlled trial. PLoS One 9(3), e89511. https://doi.org/10.1371/journal.pone.0089511.

Sharma V, Sharma C, Chauhan S, Kaur S. 2018. Effect of lactation age and storage on the antibacterial potency of human breast milk against neonatal pathogens. Journal of Pure and Applied Microbiology 12(3), 1307–1314. https://doi.org/10.22207/JPAM.12.3.33.

Silvestre D, Ruiz P, Martínez-Costa C, Plaza A, López MC. 2008. Effect of pasteurization on the bactericidal capacity of human milk. Journal of Human Lactation 24(4), 371–376. https://doi.org/10.1177/0890334408319158.

Tully DB, Jones F, Tully MR. 2001. Donor milk: What’s in it and what’s not. Journal of Human Lactation 17(2), 152–155. https://doi.org/10.1177/089033440101700212.

Viazis S, Farkas BE, Allen JC. 2007. Effects of high-pressure processing on immunoglobulin A and lysozyme activity in human milk. Journal of Human Lactation 23(3), 253–261. https://doi.org/10.1177/0890334407303945.

Wagner CL, Anderson DM, Pittard WB III. 1996. Special properties of human milk. Clinical Pediatrics (Phila) 35(6), 283–293. https://doi.org/10.1177/000992289603500601.

Wills ME, Han VE, Harris DA, Baum JD. 1982. Short-time low-temperature pasteurization of human milk. Early Human Development 7(1), 71–80. https://doi.org/10.1016/0378-3782(82)90009-3.

Woodman T, Strunk T, Patole S, Hartmann B, Simmer K, Currie A. 2018. Effects of lactoferrin on neonatal pathogens and Bifidobacterium breve in human breast milk. PLoS One 13(8), 1–14. https://doi.org/10.1371/journal.pone.0201819.

Related Articles

Comparative responses of rice (Oryza sativa L.) to iron toxicity, drought and salinity stress: Morphological, physiological, biochemical and molecular regulation mechanisms

Yaya Touré*, Brahima André Soumahoro, Arthur Martin Affery, Tchoa Koné, Mongomaké Koné, Int. J. Biosci. 28(6), 37-50, June 2026.

Biocontrol potential of indigenous fungal antagonists from soils naturally suppressive to Fusarium oxysporum f. sp. cubense tropical race 4

Arnel V. Somolostro*, Carolina D. Amper, Mellprie B. Marin, Darwin M. Apistar, Myrna G. Ballentes, Ailyn Q. Daniel, Int. J. Biosci. 28(6), 27-36, June 2026.

Basal stem rot of oil palm in Africa: Emerging epidemiology, pathogen diversity and future management challenges

Emmanuel Fumbuka Mabula*, Agatha Aloyce, Alfonce Leonard, Pavithravani B. Venkataramana, Int. J. Biosci. 28(6), 13-26, June 2026.

The role of aberrant glycosylation in autoimmune disease development and progression

Md. Nafis Fuad Prottoy, Sayad Md. Didarul Alam*, Int. J. Biosci. 28(6), 1-12, June 2026.

Solvents’ influence on polyphenolic compound extractions from Lippia multiflora leaves (Mold, 1949), and their antioxidant activity

Kelemin Awa Koné*, Tagouèlbè Tiho, Mariam Sanogo, Casimir Kekou, Kouassi Hervé Tani, Int. J. Biosci. 28(5), 109-116, May 2026.

Economics of selected cropping system practices in the province of La Union, Philippines

Jennifer A. Cabading, V. Sagun Analyn, Angelina T. Gonzales*, Int. J. Biosci. 28(5), 97-108, May 2026.

The hidden burden: A review of toxicity from femoral orthopedic implants

Haroon Habib Beigh*, Nabeel Khan, Mirza Masroor Ali Beg, Int. J. Biosci. 28(5), 84-96, May 2026.